本文關(guān)鍵詞： 狼瘡性腎炎 腎小管間質(zhì)病變 P-選擇素 磁共振功能成像　出處：《上海交通大學(xué)》2015年博士論文　論文類型：學(xué)位論文

【摘要】：狼瘡性腎炎(LN)是我國(guó)最常見的繼發(fā)性腎小球腎炎之一,主要臨床表現(xiàn)為蛋白尿、血尿,嚴(yán)重者可出現(xiàn)腎病綜合征,甚至腎功能不全。2003年國(guó)際腎臟病協(xié)會(huì)和腎臟病理組織(ISN/RPS)主要依據(jù)腎小球病變情況對(duì)LN進(jìn)行了分型。事實(shí)上,60%~70%LN患者可出現(xiàn)不同程度的腎小管損害、腎間質(zhì)炎癥和纖維化,而且腎小管間質(zhì)病變的嚴(yán)重程度直接影響了LN的進(jìn)展速度和預(yù)后。在LN的小管間質(zhì)病變發(fā)生過程中,免疫損傷可能導(dǎo)致腎血管內(nèi)皮細(xì)胞活化、組織缺血缺氧,腎內(nèi)活性氧(ROS)大量產(chǎn)生,在ROS、P-選擇素以及促分裂素原活化蛋白激酶作用下中性粒細(xì)胞聚集粘附,進(jìn)而加重了腎小管間質(zhì)損傷。細(xì)胞黏附分子P-選擇素主要表達(dá)在活化的血小板/內(nèi)皮細(xì)胞表面,是在炎癥早期介導(dǎo)中性粒細(xì)胞于血管內(nèi)皮滾動(dòng)和初始黏附的關(guān)鍵成分,可促使炎癥部位中性粒細(xì)胞募集,在LN小管間質(zhì)病變中可能起到重要作用。本研究利用磁共振(MR)功能成像方法觀察經(jīng)P-選擇素單克隆抗體治療前后LN動(dòng)物模型(MRL/lpr小鼠)腎臟的功能、缺氧狀態(tài)和病理變化,探討LN腎小管間質(zhì)病變的病理機(jī)制以及P-選擇素單抗對(duì)LN的早期干預(yù)和治療作用,同時(shí)探討MR功能成像在狼瘡性腎炎腎臟病變、氧合水平的動(dòng)態(tài)監(jiān)測(cè)和療效評(píng)估方面的價(jià)值。研究的第一部分對(duì)65例LN患者和16例健康志愿者進(jìn)行了腎臟擴(kuò)散加權(quán)成像(DWI)及血氧水平依賴法(BOLD)成像。分析LN患者的腎臟表觀擴(kuò)散系數(shù)(ADC)和表觀自旋-自旋弛豫率(R2*)值與臨床指標(biāo)和病理改變的關(guān)系。結(jié)果發(fā)現(xiàn)LN腎臟的ADC值為(2.40±0.25)x10-3mm2/s,皮、髓質(zhì)R2*值分別為11.03±1.60/sec和14.05±3.38/sec,均顯著低于正常腎臟測(cè)值(分別P=0.048,P=0.045和P=0.008)。LN腎臟ADC值與eGFR顯著相關(guān)(r=0.510,P0.01),與腎臟病理慢性指數(shù)呈負(fù)相關(guān)(r=-0.249,P0.05)。髓質(zhì)R2*值與24小時(shí)尿蛋白、腎小管間質(zhì)病變程度均呈負(fù)相關(guān)(r分別為-0.244和-0.242,P0.05)。65例LN患者中16例經(jīng)過9~12個(gè)月免疫誘導(dǎo)治療后再次行MR功能成像,發(fā)現(xiàn)完全緩解者腎臟ADC值和R2*值較前顯著升高。研究表明DWI成像和BOLD成像檢查為動(dòng)態(tài)監(jiān)測(cè)LN腎功能損害和腎組織病理改變提供了一種無創(chuàng)性方法,可能為臨床干預(yù)的療效評(píng)價(jià)提供依據(jù)。研究的第二部分以自發(fā)性LN模型MRL/lpr小鼠作為研究對(duì)象,其尿蛋白、血清肌酐、抗ds-DNA抗體均顯著高于對(duì)照組C57BL/6小鼠,自12周齡起腎小球系膜細(xì)胞增生、基底膜增厚,腎小管上皮細(xì)胞脫落,腎間質(zhì)炎細(xì)胞浸潤(rùn),尤其是血管周圍炎細(xì)胞大量聚集。采用免疫組化、Western blot方法發(fā)現(xiàn)在LN模型小鼠腎組織中有缺氧探針HypoxyprobeTM-1、缺氧標(biāo)志物HIF-1α和對(duì)組織缺氧有保護(hù)作用的HO-1蛋白廣泛分布,并與腎小管間質(zhì)病變密切相關(guān),MR功能成像腎臟ADC值與尿蛋白、血肌酐呈負(fù)相關(guān),平均R2*值與尿蛋白、腎小管間質(zhì)病變程度及腎組織缺氧指標(biāo)表達(dá)均呈負(fù)相關(guān)。結(jié)果提示腎內(nèi)缺氧是導(dǎo)致LN腎小管間質(zhì)病變的關(guān)鍵因素之一,功能MRI可反映LN腎臟病變及腎內(nèi)缺氧情況。研究的第三部分采用免疫組化、Western blot和實(shí)時(shí)熒光定量PCR方法發(fā)現(xiàn)LN小鼠腎組織中P-選擇素蛋白和m RNA表達(dá)顯著上調(diào)。采用P-選擇素單抗對(duì)MRL/lpr小鼠進(jìn)行早期干預(yù),缺氧探針HypoxyprobeTM-1、HIF-1α和HO-1蛋白分布和mRNA表達(dá)較未干預(yù)組和生理鹽水對(duì)照組均下降,且腎小管間質(zhì)病變的嚴(yán)重程度減輕。MR功能成像R2*值與腎小管間質(zhì)病變程度及腎組織缺氧指標(biāo)表達(dá)均呈負(fù)相關(guān)。提示P-選擇素在LN腎組織表達(dá)上調(diào),可能參與啟動(dòng)LN腎小管間質(zhì)早期的炎癥反應(yīng)和病理?yè)p傷,BOLD-MRI可動(dòng)態(tài)監(jiān)測(cè)LN干預(yù)前后腎內(nèi)氧合狀態(tài)�？傊�,本研究表明腎內(nèi)缺氧可能是導(dǎo)致LN腎小管間質(zhì)病變的一個(gè)關(guān)鍵因素,P-選擇素單抗干預(yù)可改善LN腎內(nèi)缺氧及腎小管間質(zhì)病變程度,功能MRI為動(dòng)態(tài)監(jiān)測(cè)LN腎臟病變、氧合水平和療效評(píng)價(jià)提供了一種無創(chuàng)性方法,對(duì)于臨床上LN的早期診治、療效監(jiān)測(cè)和預(yù)后評(píng)估具有重要意義。
[Abstract]:Lupus nephritis (LN) is one of the most common secondary glomerulonephritis in our country, the main clinical manifestations were proteinuria, hematuria, serious person can appear in nephrotic syndrome, and renal insufficiency in.2003 international society of Nephrology and renal pathology (ISN/RPS) mainly on the basis of glomerular lesions were divided into type of LN. In fact, 60%~70%LN can occur in patients with renal tubular injury and renal interstitial inflammation and fibrosis, and the severity of tubulointerstitial changes directly affect the progression and prognosis of LN. In the process of quality LN tubule lesions, immune injury may lead to renal vascular endothelial cell activation, organization hypoxia ischemia, active oxygen in the kidney (ROS) produced in ROS, P-, P-selectin and mitogen activated protein kinase in neutrophil adhesion and aggregation effect, aggravate tubulointerstitial injury. Cell adhesion molecule P- selectin is mainly expressed on the surface of activated platelet / endothelial cells, is a key ingredient in the early stage of inflammation mediated neutrophil adhesion to vascular endothelial rolling and initial, can promote inflammation neutrophil recruitment, LN in tubulointerstitial lesions may play an important role. This study used magnetic resonance (MR) functional imaging method to observe the P- element before and after monoclonal antibody in LN animal model (MRL/lpr mouse) renal function status and pathological changes of hypoxia, early intervention and treatment effect of LN on renal tubule pathological lesions and mechanism of P- selectin monoclonal antibody on LN, at the same time to explore the functional MR imaging in renal lesions of lupus nephritis dynamic monitoring and evaluation, effect of oxygenation value. The first part of the study of 65 LN patients and 16 healthy volunteers were renal diffusion weighted imaging (DWI) and blood oxygen level dependent Lai (BOLD) imaging method. Analysis of apparent diffusion coefficient in patients with kidney LN (ADC) and apparent spin spin relaxation rate (R2*) value and clinical indicators and pathological changes. The results showed that LN kidney ADC value (2.40 + 0.25) x10-3mm2/s, skin, medulla R2* = 11.03 1.60 + /sec and 14.05 + 3.38/sec were significantly lower than that of normal renal values (respectively P=0.048, P=0.045 and P=0.008).LN renal ADC value was significantly correlated with eGFR (r=0.510, P0.01), and negatively correlated with renal pathological chronic index (r=-0.249, P0.05). The R2* values of medulla and urine protein of 24 hours, the degree of renal tubule matter lesions were negatively correlated (r = -0.244 and -0.242, P0.05).65 LN patients in 16 cases after 9~12 months after treatment again for MR induced immune function imaging, found complete remission of renal ADC and R2* values significantly increased. The research showed that DWI and BOLD as imaging examination for dynamic monitoring LN renal function Changes of renal pathological damage and provides a noninvasive method, may provide the basis for the evaluation of curative effect for clinical intervention. The second part of the study on spontaneous LN model MRL/lpr mice as the research object, the urine protein, serum creatinine, anti ds-DNA antibodies were significantly higher than the control group of C57BL/6 mice, the proliferation of mesangial cells from at the age of 12 weeks, basement membrane thickening, renal tubular epithelial cell shedding, renal interstitial infiltration of inflammatory cells, especially the large accumulation of perivascular inflammatory cells. Immunohistochemical method, Western blot found that hypoxia probe HypoxyprobeTM-1 in renal tissue of LN mice, hypoxia marker HIF-1 alpha and has a protective effect on hypoxia HO-1 protein is widely distributed, and tubulointerstitial lesions are closely related, MR functional imaging of renal ADC value and urinary protein was negatively correlated with serum creatinine, the average value of R2* and urinary protein, renal tubular interstitial lesion Hypoxia index and renal tissue expression showed a negative correlation. The results showed that renal hypoxia is one of the key factors leading to mass lesions of the LN renal tubule function, MRI can reflect the renal lesions and renal hypoxia LN. The third part of the study by immunohistochemistry, Western blot and real-time fluorescence quantitative PCR method found that P- selectin m RNA and protein expression was significantly up-regulated in renal tissue of LN mice. The P- selectin monoclonal antibody for early intervention of MRL/lpr mice, hypoxia probe HypoxyprobeTM-1, expression of HIF-1 and HO-1 protein distribution and mRNA than those in the untreated group and saline control group were decreased, and the severity of renal tubulointerstitial lesions reduce functional.MR imaging R2* the value of renal tubule and hypoxia index matter lesions and renal tissue expression were negatively correlated. P- selectin in renal LN expression may be involved in the early start LN tubulointerstitial inflammation And the pathological injury and BOLD-MRI dynamic monitoring of LN before and after the intervention of renal oxygenation. In conclusion, this study shows that hypoxia may lead to LN in renal tubulointerstitial lesions is one of the key factors, P- selectin monoclonal antibody intervention can improve the severity of renal LN hypoxia and renal tubule function, MRI LN kidney disease dynamic monitoring, evaluation of the oxygenation level and curative effect provides a noninvasive method for early diagnosis and treatment of clinical LN, has important significance for evaluation of curative effect monitoring and prognosis.

【學(xué)位授予單位】：上海交通大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類號(hào)】：R593.242

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 邢迎紅;曹書華;常文秀;;可溶性P-選擇素在彌漫性血管內(nèi)凝血的臨床意義[J];陜西醫(yī)學(xué)雜志;2006年12期

2 羅玉麗;;P-選擇素基因多態(tài)性與P-選擇素蛋白關(guān)系的研究進(jìn)展[J];海峽科學(xué);2011年09期

3 李曉,周同;P-選擇素及其臨床意義[J];上海第二醫(yī)科大學(xué)學(xué)報(bào);1997年01期

4 李翠瑩,張獻(xiàn)清,李琳琳,穆士杰;血小板保存對(duì)P-選擇素的影響[J];上海醫(yī)學(xué)檢驗(yàn)雜志;2001年01期

5 趙水平,許丹焰;氧化型脂蛋白(a)對(duì)人臍靜脈血管內(nèi)皮細(xì)胞P選擇素表達(dá)的影響[J];中華心血管病雜志;2001年08期

6 姚巍,楊蘭,陳天鐸,李培杰,馬永華;可溶性P-選擇素與心血管易患因素關(guān)系的探討[J];中國(guó)急救醫(yī)學(xué);2002年01期

7 孫Ya燕,胡健,賀業(yè)軍;老年不穩(wěn)定型心絞痛患者P-選擇素的水平及意義[J];實(shí)用老年醫(yī)學(xué);2002年06期

8 陳宇杰,陸信武;P-選擇素與動(dòng)脈粥樣硬化形成[J];國(guó)外醫(yī)學(xué)(生理、病理科學(xué)與臨床分冊(cè));2002年04期

9 歐陽(yáng)桂芳,陳曉敏;纖維蛋白原、P-選擇素與冠心病相關(guān)的研究[J];浙江中西醫(yī)結(jié)合雜志;2002年06期

10 郭劍民,程向東,江獻(xiàn)川,彭承宏,劉穎斌,徐斌,彭淑牖;一氧化氮對(duì)缺血再灌注硬化肝臟P-選擇素表達(dá)的影響及保護(hù)作用[J];腫瘤研究與臨床;2002年04期

相關(guān)會(huì)議論文 前10條

1 賈瀟凌;龍勉;;L-選擇素水解斷裂對(duì)選擇素-配體反應(yīng)動(dòng)力學(xué)的影響[A];第八屆全國(guó)生物力學(xué)學(xué)術(shù)會(huì)議論文集[C];2006年

2 陳慧;楊軍軍;姚榮欣;;特發(fā)性血小板減少性紫癜患者網(wǎng)織血小板與P-選擇素測(cè)定及其臨床意義[A];第四屆全國(guó)臨床檢驗(yàn)學(xué)術(shù)會(huì)議論文匯編[C];2006年

3 賈瀟凌;龍勉;;L-選擇素水解斷裂對(duì)選擇素-配體反應(yīng)動(dòng)力學(xué)的影響[A];第十次中國(guó)生物物理學(xué)術(shù)大會(huì)論文摘要集[C];2006年

4 江小杰;黃紹烈;;可溶性血管細(xì)胞粘附分子1、可溶性E-選擇素與冠心病[A];第十次中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)心血管病學(xué)術(shù)大會(huì)暨第五次江西省中西醫(yī)結(jié)合學(xué)會(huì)心血管病學(xué)術(shù)大會(huì)論文匯編[C];2010年

5 馮忠軍;;E-選擇素基因多態(tài)性與疾病的關(guān)系研究進(jìn)展[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議資料匯編[C];2008年

6 楊麗霞;;冠心病患者血清P-選擇素變化的臨床意義[A];中華醫(yī)學(xué)會(huì)心血管病學(xué)分會(huì)第十次全國(guó)心血管病學(xué)術(shù)會(huì)議匯編[C];2008年

7 江虹;周小芳;曾婷婷;廖娟;蔣能剛;;外周血未成熟血小板比率及血小板P-選擇素表達(dá)的檢測(cè)及臨床應(yīng)用研究[A];中華醫(yī)學(xué)會(huì)第九次全國(guó)檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中國(guó)醫(yī)院協(xié)會(huì)臨床檢驗(yàn)管理專業(yè)委員會(huì)第六屆全國(guó)臨床檢驗(yàn)實(shí)驗(yàn)室管理學(xué)術(shù)會(huì)議論文匯編[C];2011年

8 卓孝福;林毅勝;黃文華;陳岑;林海娟;姜麗;劉景恩;曾嘉;王艷梅;陳穎;;漢族P-選擇素基因的多態(tài)性及與其蛋白水平的關(guān)系[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)中青年檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2012年

9 王顯剛;張文高;謝慶成;高福軍;劉龍濤;;P-選擇素與冠心病中西醫(yī)結(jié)合研究[A];第六次全國(guó)中西醫(yī)結(jié)合心血管會(huì)學(xué)術(shù)會(huì)議論文匯編[C];2002年

10 馬士新;李京波;魏盟;薛小培;劉銘雅;陳齊紅;潘曄生;張昀昀;金立仁;;急性冠狀動(dòng)脈綜合征患者早期血清可溶性P選擇素濃度與預(yù)后的關(guān)系[A];中華醫(yī)學(xué)會(huì)心血管病分會(huì)第八次全國(guó)心血管病學(xué)術(shù)會(huì)議匯編[C];2004年

相關(guān)重要報(bào)紙文章 前2條

1 辛樺;胚胎著床與L-選擇素有關(guān)[N];醫(yī)藥經(jīng)濟(jì)報(bào);2003年

2 程玉芳 徐江平;以CAMs為靶點(diǎn)研制抗炎藥物[N];中國(guó)醫(yī)藥報(bào);2005年

相關(guān)博士學(xué)位論文 前2條

1 李曉;磁共振功能成像方法評(píng)價(jià)P選擇素單抗對(duì)狼瘡性腎炎腎損害的干預(yù)作用[D];上海交通大學(xué);2015年

2 吳山;1.細(xì)胞因子在肺水腫發(fā)生中作用的研究 2.肺癌細(xì)胞P53表達(dá)及凋亡的研究[D];重慶醫(yī)科大學(xué);2002年

相關(guān)碩士學(xué)位論文 前10條

1 張志強(qiáng);急性冠脈綜合征患者P選擇素及血漿N末端前腦鈉肽水平分析[D];河北聯(lián)合大學(xué);2014年

2 陳曉瑋;戒煙對(duì)吸煙大鼠肺組織核因子-κB和E-選擇素表達(dá)的影響[D];山西醫(yī)科大學(xué);2010年

3 鐘宏;高壓培養(yǎng)對(duì)血管內(nèi)皮細(xì)胞P-選擇素和一氧化氮合酶的影響及藥物干預(yù)效果[D];江西醫(yī)學(xué)院;2001年

4 黃俊;選擇素—配體相互作用動(dòng)力學(xué)[D];重慶大學(xué);2003年

5 潘瑩;動(dòng)脈粥樣硬化兔模型中P-選擇素的表達(dá)及褪黑素的干預(yù)作用[D];安徽醫(yī)科大學(xué);2013年

6 張麗;肺癌患者血漿P-選擇素和組織因子水平的研究[D];天津醫(yī)科大學(xué);2011年

7 江濤;P-選擇素和內(nèi)皮素1在下肢動(dòng)脈硬化閉塞癥患者介入治療術(shù)后的表達(dá)[D];安徽醫(yī)科大學(xué);2012年

8 劉繼微;L-選擇素、異粘蛋白在胃癌中的表達(dá)及其相關(guān)性研究[D];承德醫(yī)學(xué)院;2014年

9 紀(jì)麗景;P-選擇素靶向超聲分子成像評(píng)價(jià)心肌缺血再灌注損傷[D];南方醫(yī)科大學(xué);2009年

10 龔科;P選擇素和E選擇素在大鼠肝缺血再灌注損傷中的作用[D];昆明醫(yī)科大學(xué);2014年

，

本文編號(hào)：1531197